Publikationen
Amyloidose-Zentrum
2022
Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement
N. Berghaus, S. Schreiner, M. Granzow, C. Müller-Tidow, U. Hegenbart, S. O. Schönland, et al.
PLoS One 2022 Vol. 17 Issue 2 Pages e0264407
Accession Number: 35213605 PMCID: PMC8880859 DOI: 10.1371/journal.pone.0264407
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880859/pdf/pone.0264407.pdf
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT
R. Machowicz, F. Suarez, W. Wiktor-Jedrzejczak, D. J. Eikema, L. C. de Wreede, H. J. Blok, et al.
Bone Marrow Transplant 2022
Accession Number: 35332305 DOI: 10.1038/s41409-022-01634-5
https://www.nature.com/articles/s41409-022-01634-5.pdf
Autologous hematopoietic cell transplantation for relapsed multiple myeloma performed with cells procured after previous transplantation-study on behalf of CMWP of the EBMT
J. Drozd-Sokołowska, L. Gras, N. Zinger, J. A. Snowden, M. Arat, G. Basak, et al.
Bone Marrow Transplant 2022
Accession Number: 35169284 DOI: 10.1038/s41409-022-01592-y
https://www.nature.com/articles/s41409-022-01592-y.pdf
Daratumumab after allogeneic hematopoietic cell transplantation for multiple myeloma is safe and synergies with pre-existing chronic graft versus host disease. A retrospective study from the CMWP EBMT
L. Vincent, L. Gras, P. Ceballos, J. Finke, J. Passweg, S. Harel, et al.
Bone Marrow Transplant 2022
Accession Number: 35013536 DOI: 10.1038/s41409-021-01560-y
https://www.nature.com/articles/s41409-021-01560-y.pdf
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation
C. Pabst, L. Benning, N. Liebers, M. Janssen, L. Caille, C. Speer, et al.
Vaccines (Basel) 2022 Vol. 10 Issue 2
Accession Number: 35214787 PMCID: PMC8876761 DOI: 10.3390/vaccines10020330
https://mdpi-res.com/d_attachment/vaccines/vaccines-10-00330/article_deploy/vaccines-10-00330.pdf
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis
N. Liebers, S. O. Schönland, C. Speer, D. Edelmann, P. Schnitzler, H. G. Kräusslich, et al.
Hemasphere 2022 Vol. 6 Issue 3 Pages e688
Accession Number: 35187406 PMCID: PMC8849404 DOI: 10.1097/hs9.0000000000000688
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849404/pdf/hs9-6-e688.pdf
Trends in autologous stem cell transplantation for newly diagnosed multiple myeloma: Changing demographics and outcomes in European Society for Blood and Marrow Transplantation centres from 1995 to 2019
D. Swan, P. J. Hayden, D. J. Eikema, L. Koster, S. Sauer, D. Blaise, et al.
Br J Haematol 2022
Accession Number: 35166376 DOI: 10.1111/bjh.18025